S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd

Uplistings & IPOs

All Uplistings & IPOs coverage

Illustrative photograph: an industrial manufacturing facility.
Uplistings & IPOs

Chilwa Minerals Added a Nasdaq Listing With a US$3.5 Million ADS Offering at $5.60, Netting About US$2.5 Million for a Malawi Explorer Whose June 30 Cash Stood at A$1.1 Million

The ASX-listed Malawi heavy-mineral-sands explorer sold 625,000 American Depositary Shares with matching five-year warrants through Maxim Group, began trading as CHWM on Oct. 1 and closed Oct. 2. Its prospectus estimates about US$2.5 million net and flags going-concern doubt if more capital is not raised.

Imogen Farrow · October 10, 2026
Illustrative photograph: laboratory research equipment.
Uplistings & IPOs

Retension Pharmaceuticals Priced 3.75 Million Shares at $12.00 for Its Nasdaq Debut, Upsized From 3.3 Million, With a Going-Concern Paragraph in Its Audit and One Drug in Phase 2b

The Falls Church, Virginia hypertension-drug developer priced at the midpoint of its $11-$13 range and lifted the share count, for about $38.9 million net. Its prospectus discloses $13.5 million of cash at June 30, a going-concern qualification on the 2025 audit and no product revenue.

Imogen Farrow · October 10, 2026
Illustrative photograph: a retail store interior.
Uplistings & IPOs

Greene Concepts' Regulation A Amendment Was Qualified Sept. 30; Five Days Later It Priced the Remaining Units at $0.0025 a Share, Below Both Its Oct. 2 Close of $0.011 and Its Own Stated Book Value of $0.06

The OTCID-quoted bottler, which completed a 1-for-80 reverse split on July 30, is offering up to 2,357,500 units of 100 shares each for $589,375 in gross proceeds under Tier 1 of Regulation A. The circular reports $29,552 of cash at April 30, substantial doubt about going-concern status, and 6 billion shares that could be issued on conversion of 60 Series B preferred shares.

Imogen Farrow · October 10, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Uplistings & IPOs

Stewards uplists from OTCID to the Nasdaq Capital Market with no offering and no new shares

The private-credit and real-assets company said Nasdaq's Listing Qualifications Department approved a direct uplisting from the OTCID Market with no concurrent public offering and no issuance of new shares, with trading under the symbol SWRD scheduled to begin on the Nasdaq Capital Market at Thursday's open. A summary of its June-quarter Form 10-Q shows a $7.236 million GAAP net loss, $136.1 million of total liabilities and a liquidity conclusion resting on a $24.0 million funding commitment from what the filing calls a related Stewards International fund.

Imogen Farrow · September 10, 2026
Illustrative photograph: the exterior of a financial district office building.
Uplistings & IPOs

Nuburu shares to resume NYSE American trading Sept. 14 after 1-for-40 reverse split

The exchange suspended the blue-laser maker's stock on July 17 under its low-selling-price rule and began delisting proceedings. A 1-for-40 reverse split effective Sept. 1 cut shares outstanding from roughly 370.5 million to about 9.3 million; it is the company's second reverse split of 2026.

Imogen Farrow · September 9, 2026
Illustrative photograph: computer server and electronics hardware.
Uplistings & IPOs

Check-Cap Closes MBody AI Merger and $10 Million Share Sale; the Nasdaq Listing Now Trades as MBAI

The Israeli-registered listed vehicle has been renamed MBody AI Ltd. and moved to the ticker MBAI. About 81 percent of the roughly 15.3 million shares outstanding are restricted securities issued to the private company's former holders, and only a majority of that block is under lock-up.

Imogen Farrow · August 28, 2026
Illustrative photograph: computer server and electronics hardware.
Uplistings & IPOs

GlobalTech's 1-for-3 Reverse Split Took Effect Thursday, Ahead of a Nasdaq Application Its Own Filing Says It Does Not Yet Meet All the Requirements For

The OTCQB-quoted company cut its share count from about 152 million to about 50 million, citing a Nasdaq Capital Market application that, by its own written account, it has not been approved for and does not currently meet all the requirements for.

Imogen Farrow · August 27, 2026
Illustrative photograph: US banknotes and coins.
Uplistings & IPOs

American Fusion Cleared FINRA and OTC Markets in Four Days. Its June Quarterly Report Shows $79,341 in Cash, 1.62 Billion Shares and a Going-Concern Warning.

The fusion developer says OTCQB is a step toward a Nasdaq or Texas Stock Exchange listing. Its June quarter filing lists 2.45 billion potentially dilutive underlying shares against an authorized ceiling of 1.8 billion, and it has not announced an exchange application, a share consolidation or terms for the $50 million raise.

Imogen Farrow · August 25, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Uplistings & IPOs

NuRAN's C$7.6 Million Nasdaq Financing Brought In C$3 Million of Cash. The Other C$4.6 Million Cleared Debt.

NuRAN Wireless says Nasdaq has approved its common shares for the Capital Market and that trading is expected to begin Monday under the ticker NUR. The preferred-share placement that closed after Friday's bell settled a convertible debenture, supplier bills and three executives' unpaid salaries.

Imogen Farrow · August 16, 2026
Illustrative photograph: the exterior of a financial district office building.
Uplistings & IPOs

The IPO market is raising record money while the smallest deals quietly disappear

Ninety-nine US IPOs have priced in 2026 against $145.3 billion raised, but the micro-cap end of the calendar has thinned to roughly a dozen deals as listing standards tighten.

Imogen Farrow · August 12, 2026
Illustrative photograph: laboratory research equipment.
Uplistings & IPOs

BioStem Technologies Graduates to Nasdaq as the Small-Cap Listing Window Stays Open

The Florida tissue-allograft maker began trading on the Nasdaq Capital Market on August 7, joining a 2026 new-listings calendar that is running ahead of last year's pace.

Imogen Farrow · August 11, 2026
Illustrative photograph: US banknotes and coins.
Uplistings & IPOs

First Phosphate Skips a Rung: ADR Uplisting Lands the LFP Developer on the Nasdaq Global Market

The Quebec-focused phosphate company moved its American Depositary Receipts from OTCQX to the Nasdaq Global Market on August 10 under the ticker PHOS — a cross-border listing route that raised no new capital and issued no new shares.

Imogen Farrow · August 11, 2026